Publications by authors named "D Doug Cochrane"

Aims: Mesonephric-like adenocarcinoma (MLA) of the endometrium is often a diagnostic challenge, due to its morphological resemblance to other more common Müllerian neoplasms. This study aimed to retrospectively identify overlooked MLA in a large endometrial carcinoma cohort, using a combination of immunohistochemistry (IHC), morphology and KRAS sequencing.

Methods And Results: IHC was conducted on 1094 endometrial carcinomas, identifying 16 potential MLA cases based on GATA3+ and/or TTF1+ and ER- staining patterns, which subsequently underwent detailed histological review, KRAS sequencing and ProMisE molecular classification.

View Article and Find Full Text PDF

Objectives: To identify descriptors associated with success in apprentice jockeys and to determine optimum numbers of jockeys for safer race riding.

Design: Retrospective cohort study.

Methods: Incidence-rates for jockey falls and success (wins per 1,000 race-starts), time and number of races spent at different apprentice levels were calculated for 807 apprentice and professional jockeys over 19 years of Thoroughbred flat racing in New Zealand (n = 524,551 race-starts).

View Article and Find Full Text PDF

We conducted a pre-registered meta-analysis of studies that directly compared the predictive validity of risk assessment tools to unstructured judgments of risk for violent, any, or sexual offending. A total of 31 studies, containing 169 effect sizes from 45,673 risk judgments, met inclusion criteria. Based on the results of three-level mixed-effects meta-regression models, the predictive validity of total scores on risk assessment tools was significantly higher than that of unstructured judgments for predictions of violent, any, and sexual offending.

View Article and Find Full Text PDF

Clear cell ovarian carcinoma (CCOC) is an aggressive malignancy affecting younger women. Despite ovarian cancer subtypes having diverse molecular and clinical characteristics, the mainstay of treatment for advanced stage disease remains cytotoxic chemotherapy. Late stage CCOC is resistant to conventional chemotherapy, which means a suboptimal outcome for patients affected.

View Article and Find Full Text PDF
Article Synopsis
  • Low-grade serous ovarian carcinoma (LGSC) is a rare and dangerous type of ovarian cancer that is different from the more common high-grade version.
  • Researchers studied tissue samples from LGSC, high-grade serous ovarian carcinoma (HGSC), and serous borderline tumors (SBTs) to understand how they differ.
  • They found that the environment around the tumors was different in LGSC, including specific proteins and immune cells, which suggests that changing this environment could help develop new treatments.
View Article and Find Full Text PDF